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Abstract 
 
A new application of QuEChERS (Quick, Easy, Cheap, Efficient, Rugged, and Safe) extraction 
followed by enhanced matrix removal-lipid cleanup and GC-MS analysis is proposed for skin care 
products. The method was applied to determine methyldibromo glutaronitrile (MDBGN), a 
preservative frequently used in cosmetic products before being banned for its allergic reactions, so 
as to unmask its now-prohibited use. The new validated procedure consists in extracting the 
cosmetic products with acetonitrile, removing the lipid matrix and then water and solid particles 
from the organic mixture by two dispersive solid-phase extractions (dSPE) in sequence and, lastly, 
analysing the extracts in GC-MS. Compared to classic liquid-liquid extraction with chloroform, the 
method has superior features in terms of applicability to cosmetics, ease of use, working times 
optimization and, above all, reduction of analytically interfering lipidic constituents. 
 
 
 
  
Practical applications 
The use of EMR-Lipid dSPE system followed by GC-MS analysis allowed to trace and quantify a 
minimal amount of a banned preservative, MDBGN, in so-called "complex" matrices, such as  
cosmetic creams, managing them in a simple and efficient way. Therefore, this system can be 
proposed for further applications of extractive procedures, advantageously alternative to the 
classic liquid-liquid extractions, in the field of cosmetics analysis.  
The EMR-Lipid dSPE system showed the following advantages: much simpler use, as the system 
provides tubes already packaged with the clean-up phase, optimization of the working times and 
noticeable reduction of extraction impurities allowing cleaner extracts to be obtained. 
 
  
Graphical abstract  
  
A new application of QuEChERS (Quick, Easy, Cheap, Efficient, Rugged, and Safe) 
extraction followed by enhanced matrix removal-lipid cleanup and GC-MS analysis is 
proposed for skin care products. Compared to classic liquid-liquid extraction with 
chloroform (A), the method has superior features in terms of applicability to cosmetics, 
ease of use, working times optimization and, above all, reduction of analytically interfering 
lipidic constituents (B). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Introduction 
Sample preparation is always necessary when chromatographic analysis is to be applied. 
The main purpose is to transform the sample into a system suitable for the requested aim: 
this step becomes fundamental since the primary objective is to obtain a sample that is 
relatively free of interference, has appropriate chemico-physical characteristics for the 
analytical method adopted and does not damage the chromatographic columns and/or 
instruments. Although the main analytical techniques, currently available on the market, 
are almost fully automated, in most cases the pre-treatment of the sample is still an 
exclusively manual operation, requiring a lot of time to develop the method. The 
development of a sample treatment requires careful and early planning especially dealing 
with complex matrices. A well planned sample preparation procedure should lead to 
complete analytes recovery in order to improve sensitivity, precision and accuracy of the 
method, be carried out with a minimum number of steps by reducing the overall time and 
effort required, and be as automated as possible with the aim of reducing the inaccuracy 
and precision errors of the analyst. [1-5] 
Generally, the separation of analytes of interest from complex matrices is carried out by 
the application of extractive methods. For liquid (or semi solid) samples, the main 
extraction techniques used are liquid-liquid extraction (LLE), or solid phase extractions 
(SPE). In liquid-liquid extractions, extraction solvents such as hexane, acetone, ethyl 
acetate and dichloromethane may produce complete extraction efficiencies for lipophilic 
analytes, but may require long and costly steps. Cosmetic products, and in particular 
creams, are generally semi-solid emulsions of oil in water, consisting of a significant lipid 
fraction and numerous components with different physical and chemical properties. 
Interference from lipids is a common problem for all laboratories handling fat complex 
biological matrices: their presence in a sample could cause remarkable interference, 
resulting in ion suppression and thus adversely affect sample analysis.   
Isolating a lipophilic component in these matrices is a difficult task; in fact, choosing a 
selective solvent able to extract exclusively the component of interest without dragging the 
unwanted lipid fraction is almost impossible. 
The aim of this work is to propose a new application of sample purification able to produce 
clean extracts by selectively eliminating lipids from complex matrices without loss of 
analytes, making sample preparation simple, fast and, above all, reducing the amount of 
matrix inserts in the instrument. In fact, lipids can accumulate in the column and 
instrument, reducing the life of the column itself and increasing the frequency of 
maintenance of the instrument. 
The QuEChERS extraction method (Quick, Easy, Cheap, Efficient, Rugged, and Safe) was 
applied in this work with some modifications to analyse cosmetic products, such as creams 
and milks, in order to establish whether prohibited methyldibromo glutaronitrile (MDBGN) 
was present. The analyses were required by a Northern Italy tribunal on commercial 
cosmetics whose labels declared, due to a labelling mistake according to the producer, the 
presence of MDBGN and, what’s more, without percentage indication. The QuEChERS 
method was originally developed and utilized for pesticide analysis on samples coming 
from a large variety of matrices (meat, fish, fruits and vegetables) [6]. Here, in particular, 
the applicability of Agilent Technologies' Bond Elut Enhanced Matrix Removal-Lipid (EMR-
  
Lipid) system [7-9] was evaluated on cosmetic creams and milks and the results were 
compared with those obtained by a classic liquid-liquid extraction in chloroform.  
MDBGN (Fig. 1) is a preservative with a potent and clinically significant allergen activity, 
that has been frequently used since the beginning of the 1980s in industrial and cosmetic 
products. In 1986, the European Union (EU) Scientific Committee on Cosmetology 
approved its use in cosmetics at a maximum concentration of 0.1% with the exception of 
sunscreen products, where the concentration limit was fixed at 0.025%[10].  
In 2002 following a substantial increase in cases of eczema, contact dermatitis and allergic 
phenomena[11], the European Commission (EC), based on the opinion of the Scientific 
Committee on Cosmetology, proposed to prohibit the use of MDBGN in non-rinse products 
(leave- On) and to limit its use to only rinsing products, until the actual risk of this 
compound had been evaluated at normal concentrations of use. The results of numerous 
surveys led to the development of European Directive 2003/83 / EC, in which the EC has 
decided to limit the use of MDBGN exclusively to rinsing cosmetic products setting the 
maximum permissible concentration to 0.1%.[12] However, in recent years, due to a 
continuous increase in adverse reactions associated with the MDBGN, the EC, with the 
Community Directive 2007/17 / EC, which was transposed into Italy by a Ministerial 
Decree of January 2008, forbad the presence of the preservative in all circulating 
cosmetics in the EU.[13].  
 
Materials and methods 
 
Chemicals and reagents 
Acetonitrile HPLC grade (99.9%), methanol (>96%), chloroform (>99,0%), MDBGN, 4-
Bromobutyronitrile (IS) (97%), diethoxyacetonitrile and sodium sulfate were purchased 
from Sigma Aldrich (Milan, Italy). Ethyl 2,3-dibromopropionate was prepared according to 
a literature method as reported in literature.[14] All reagents were of analytical grade and 
stored as required by their specifics. Stock standard solutions (1 mg/mL) of MDBGN and 
IS were prepared in methanol and stored at 4°C for up to a month. 
Water (18.2 ·cm-1) was prepared by a Milli-Q System (Millipore, Darmstadt, Germany). A 
dispersive-solid phase extraction kit (EMR—Lipid dSPE, Part No 5982-1010) containing an 
EMR-Lipid sorbent and Final Polish EMR-Lipid (Part No 5982-0101) containing a mixture 
of magnesium sulfate and sodium chloride were purchased from Agilent Technologies 
(Santa Clara, CA). 
 
Cosmetic products 
Different cosmetic products were analysed for evaluating the presence of MDBGN: 
n. 2 glycolic acid face creams with mallow and aloe, 50 mL; 
n. 1 fat and impure skins daily cream, 50 mL; 
n. 1 tonic with chamomile and hamamelis distilled water, 500 mL; 
n. 1 thermic body massage cream, 1000 mL; 
n. 1 cold body massage cream, 1000 mL; 
n. 1 detergent milk, 2000 mL; 
  
n. 1 detergent milk with mallow and chamomile extract, 500 mL; 
n. 1 detergent milk with mallow and chamomile extract, 250 mL; 
n. 1 body massage creams with seaweeds extract, 1000 mL. 
The INCI labels of all products contain the caption “methyldibromo glutaronitrile” (MDBGN) 
without indication of substance percentage. All samples were initially screened for MDBGN 
by applying a liquid-liquid extraction in chloroform. Only the positive samples, in the 
presence of MDBGN, were analysed by using the EMR-Lipid dSPE.  
 
Sample preparation: liquid – liquid extraction  
Aliquots (1 g or 1 mL) of the cosmetic products were accurately weighted into a 15 mL 
volumetric flask and 200 µL of IS stock solution, 5 mL of water and 5 mL of chloroform 
were added. The mixture was vigorously shaken for 30 s by vortex, extracted in an 
automatic rotatory extractor for 5 min and centrifuged at 5500 rpm for 5 min. The organic 
phase was separated, added with sodium sulfate and centrifuged for 5 min. The extract 
was transferred to a vial for gas-cromatography analysis. 1µL was injected. 
 
Sample preparation: EMR-Lipid dSPE 
Aliquots (1 g) of the cosmetic products were accurately weighted into a 15 mL volumetric 
flask and 200 µL of IS stock solution and 10 mL of acetonitrile were added. The mixture 
was vigorously shaken for 30 s by vortex, extracted in an automatic rotatory extractor for 5 
min and centrifuged at  6764 g for 5 min. 5 mL of water were added for the activation of 
EMR-Lipid dSPE 15 mL tube already containing the sorbent for cleanup step, then 5 mL of 
the previous organic mixture were transferred. The mixture was vigorously shaken for 30 s 
by vortex, extracted in an automatic rotatory extractor for 5 min and centrifuged at 6764 g 
for 5 min. 5 mL of extract were transferred to a Final Polish EMR-Lipid tube. The mixture 
was homogenized during 1 min in vortex, centrifuged and 2 mL of extract were transferred 
to a vial for gas-chromatography analysis. 1 µL was injected. 
 
Instrumentation and conditions 
GC–MS analyses were carried out on a 6890 Series Plus gas chromatograph equipped 
with an Agilent 7683 autosampler and coupled to a 5973N mass selective detector (Agilent 
Technologies, Palo Alto, CA, USA). Data were analysed with MSD ChemStation D.03.00 
software (Agilent Technologies). Chromatographic separation was carried out on a RXI- 
5sil-MS capillary column (30 m × 0.25 mm I.D., thickness 0.25 µm; Restek Bellefonte PA, 
US) and split injection mode (30:1) was used. The GC-MS system was operated under the 
following conditions: injection temperature: 280°C; interface transfer line: 280°C; ion 
source: 230°C; initial column temperature: 70°C. The temperature was subsequently 
increased to 190°C at a rate of 15°C min-1, then to 300°C at a rate of 40°C min-1 and held 
at this temperature for 3.25 min. Helium was used as carrier gas at a flow rate of 1.2 mL/ 
min. MS analysis was performed in SCAN (40-550 m/z) and SIM mode with a quadrupole 
mass detector operated in electron ionization mode, with beam energy of 70 eV. The ions 
selected for SIM mode acquisition were 106, 66, 52 for MDBGN and 68, 54 for IS (in bold 
the quantifier ions). 
 
 
  
Validation 
Prior to application to real samples, the methods, liquid – liquid extraction and EMR-Lipid 
dSPE, were tested in a validation protocol scheme following the accepted criteria for 
bioanalytical method validation. [15] Validation protocol applied in the present study 
included specificity, precision, accuracy, linearity and limits of detection (LOD) and 
quantification (LOQ). Standard samples containing different MDBGN amounts were 
prepared by adding suitable amounts of standard stock solutions of MDBGN to 1 g of “fat 
and impure skins daily creams” which were negative at the presence of the MDBGN. The 
standard samples were then treated as reported in the "sample preparation" section.  
The specificity was assessed by extracting control blank samples in each validation run. 
The lack of interfering peaks at the same analyte retention times was considered as an 
acceptable selectivity.  
Validation parameters for precision and accuracy were calculated using different replicates 
of samples in different working days. Accuracy was expressed as the percent recovery 
(%REC), while precision was measured as coefficient of variation (CV%). A CV% below 
10% was considered suitable. 
Calibration curves were calculated by plotting peak area MDBGN/ area IS versus the total 
amount (µg) of MDBGN added in the range 50-800 (50, 100, 250, 500, 800) total µg of 
analyte in 1 g of blank matrix.  
The LOD, defined as the lowest concentration of analyte that can be clearly detected, is 
estimated as three times the signal to noise ratio. LOQ is the lowest concentration that met 
a signal-to-noise ratio of at least 10.  
 
Results and Discussion 
 
Method development 
During the development of the method for the determination of MDBGN, different 
compounds were considered for the selection of the internal standard. In particular, the 
following molecules have been studied: 4-bromobutyronitrile (A), ethyl 2,3-
dibromopropionate (B), and diethoxyacetonitrile (C) (Fig. 1). Diethoxyacetonitrile was 
discarded because it was not suitable for use in GC/MS under the adopted conditions due 
to a too short retention time. Ethyl 2,3-dibromopropionate initially seemed to be the most 
suitable molecule, but it was subsequently discarded owing to poor solubility in the 
solvents used in MDBGN extraction procedures, leading to very high coefficient of 
variation values (CV%) and therefore inadequate for the purpose. On the other hand, 4-
bromobutyronitrile was found to be relevant as IS for two reasons: first for its chemical 
structure characterized by the presence of bromine atom and nitrile group as well as in the 
MDBGN molecule, and secondly for its chromatographic behaviour which was very similar 
to the molecule of interest (Fig. 2). Moreover the reproducibility and recovery values 
obtained were acceptable. 
A study on the injection system (split/splitless) and on injector temperature was also 
necessary. The most suitable injection system was the split method under the conditions 
described in the method. The splitless method led to excellent responses in terms of 
absolute area for the MDBGN molecule, but to a loss in resolution for the IS molecule.  
  
Therefore, it was decided to work in split mode since sensitivity was good enough for the 
purposes of this work.  
The working temperature of the injector was evaluated in a temperature range of 150 to 
290°C by analysing a 100 µg/mL MDBGN solution. The chosen working temperature was 
220°C because at this value the highest response and resolution of the MDBGN peak 
were obtained. 
 
 
Validation parameters 
The results obtained from the validation study fulfilled the expectations for both methods.  
Initially, all tested products were subjected to liquid-liquid extraction as reported and no 
interfering peaks appeared at the retention time of the MDBGN and IS molecule.  
The specificity was evaluated also for the EMR-Lipid dSPE technique, confirming the 
expected data.  
The precision and accuracy results are reported in Table 1 for both methods: accuracy 
values never above 10% (expected value) and recovery values around 100% were 
obtained. These results were attained by testing standard samples with 200 µg/g MDBGN 
concentration in replicate. 
The linearity was proven according to the regression line by the method of least squares 
and expressed by the coefficient of determination (R2). Five-point matrix-matched 
calibration curves were evaluated by spiking increasing amounts of the analyte in blank 
matrix samples. Calibration curves were obtained by plotting the ratio between the peak 
area of the quantifier ion of the analyte and the peak area of the quantifier ion of the 
internal standard versus the corresponding concentrations of the analytes in concentration 
range between 50 and 800 µg/g of MDBGN. We observed linearity in the whole range. The 
values of the correlation factors R2 of the calibration curves were higher than 0.99. The 
LOD and LOQ values obtained were respectively 10 and 50 μg/g suitable for the purposes 
of the work (Table 2). 
 
Analysis of skin care products 
The EMR-Lipid dSPE system was first applied in our laboratory as an effective lipophilic 
fraction removal matrix system. As mentioned before, the presence of lipids (fatty acids, 
phospholipids, cholesterol, etc...) may cause significant interference and adversely affect 
the sample analysis. In fact, lipids can accumulate in the column and instrument, reducing 
the life of the column itself and increasing the frequency of instrument maintenance. This 
new matrix purification system was applied to cosmetic creams evaluating the applicability 
of the method in terms of ease of application, reduced consumption, speed of execution 
and cleaning of extracts compared to a classic liquid-liquid extraction.   
This system is available on the market in a ready-to-use form. It consists of two falcon-type 
tubes: the first tube contains a solid extraction phase in which the lipid and fat functions 
are mainly retained, the second tube contains a mixture of magnesium sulphate and 
sodium chloride for an effective removal of water and dispersed solid particles. The tubes 
are characterized by caps of different colours that identify the contents of the tubes, greatly 
limiting the possibility of error by the operator. The advantage of having many samples in 
  
pre-prepared tubes is that it is possible to prepare many samples at the same time with 
low error chance by operators and, above all, to make the preparation systematic. In 
addition, relatively simple laboratory equipment is required: an extractor and a centrifuge. 
For our work, the extract obtained did not need to be concentrated, but this system allows 
to do that if necessary.  
MDBGN was detected only in the two samples of glycolic acid face creams with mallow 
and aloe. The concentration of MDBGN (Table 3) determined by the two different 
extraction procedures were comparable: 0.022% by liquid-liquid extraction and 0.019% by 
EMR-Lipid dSPE system. Therefore, both extraction methods can be considered  effective. 
Nevertheless, the EMR-Lipid dSPE system showed the following advantages: much 
simpler use, as the system provides tubes already packaged with the cleanup phase, 
optimization of the working times and noticeable reduction of extraction impurities allowing 
cleaner extracts to be obtained. From the chromatograms reported in Fig. 3, it is evident 
that the extract obtained after LLE contains a lot of impurities related to the matrix (peaks 
from 10.50 to 14.50 min, Fig. 3A), that interfere with the analysis and cause damage to the 
chromatographic column. On the other hand, the extract obtained after the application of 
the EMR-Lipid dSPE method is considerably cleaner (Fig. 3B). In Fig. 3A and 3B the Full 
Scan acquisition mode is reported. In the insets, the SIM (single ion monitoring) acquisition 
is shown to evidence the presence of the analyte and the IS in the extract.  
With regard to the tribunal’s request and to the potential allergenic activity of the analysed 
cream samples, it must be pointed out that, although the found MDBGN concentration was 
very low, this glycolic acid face cream is classified as a cosmetic product without rinsing 
(leave-on product) suitable for daily application and that MDBGN was allowed at 0.025% 
concentration in non-rinse product before 2002, completely banned from these products 
after 2002 and prohibited in cosmetic products of any kind in 2007. Such prescriptions do 
not leave room for any objections regarding real likelihood of health damage at this 
MDBGN concentration and at the recommended frequency of product application.  
 
 
Conclusion 
 
The use of EMR-Lipid dSPE system followed by GC-MS analysis allowed to trace and 
quantify a minimal amount of a banned preservative, MDBGN, in so-called "complex" 
matrices, such as  cosmetic creams, managing them in a simple and efficient way. 
Therefore, this system can be proposed for further applications of extractive procedures, 
advantageously alternative to the classic liquid-liquid extractions, in the field of cosmetics 
analysis.  
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Table 1. Validation parameters: intra-interday precision and accuracy of MDBGN in cream samples. 
 
 
 
 
 
 
 
 
 
Table 2. Validation parameters: calibration curve parameters, LOD and LOQ of MDBGN. 
 
Method Range (µg tot) n= 5 Linearity equation 
 
Correlation Coefficient 
(R
2
) 
LOD 
(µg/g) 
LOQ 
(µg/g) 
EMR-Lipid 50-800 y = 0.0051x – 0.1367 0.9985 10 50 
LLE 50-800 y = 0.0053x – 0.0417 1.0000 10 50 
 
 
Table 3 Concentration and percentage of MDBGN in seized cosmetic products. 
 
 
EMR-Lipid LLE 
Cosmetic product MDBGN (µg/g) 
(n=6) 
% MDBGN MDBGN (µg/g) 
(n=6) 
% MDBGN 
Glycolic acid face cream 187.8 ± 11.5 0.019 224.6 ± 17.3 0.022 
Fat and impure skins daily cream n.d. n.d. n.d. n.d. 
Tonic - - n.d. n.d. 
Thermic body massage cream - - n.d. n.d. 
Cold body massage cream - - n.d. n.d. 
Detergent milk - - n.d. n.d. 
Body massage cream with seaweeds extract - - n.d. n.d. 
n.d. = not detected 
 
Method Precision  
(CV%) n=6 
Accuracy  
(REC%) n=5 
intraday interday  
EMR-Lipid 
7.2 7.7 100.0 
LLE 
8.0 8.2 103.2 
  
 
 
 
Fig. 1 The chemical structure of methyldibromo glutaronitrile (MDBGN, A), 4-bromobutyronitrile (B), ethyl 
2,3-dibromopropionate (C), and diethoxyacetonitrile (D). 
  A 
 
M.W. = 265,93 
 B 
M.W. = 148,00  
  C 
M.W. = 259.92  
  D 
M.W. = 129.16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. 2 GC-MS chromatogram in selected ion monitoring (SIM) and mass spectrum of a standard solution of 
IS (tR = 3.928 min) and MDBGN 1mg/mL (tR = 4.474 min). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. 3: GC-MS chromatograms in Full Scan mode of a sample of face cream extract with LLE (A) and EMR-
Lipid dSPE (B). In the inset the SIM acquisition is reported. 
 
 
 
 
 
 
  
 
 
 
